Abstract
Objective Depression is a heterogeneous disorder. The purpose of this article is to examine the contribution of age to this heterogeneity by characterizing the associations of depressive symptoms with cognitive performance and brain structure across the lifespan.
Methods The authors analyzed demographic variables (age, gender, education), affective measures (Hospital Anxiety and Depression Scale), and cognitive assessments (The Addenbrooke’s Cognitive Examination Revised) from the Cambridge Centre for Ageing Neuroscience (Cam-CAN) cohort (N=2591, age 18-99). A subset of this cohort (N=647) underwent structural MRI, which was used for voxel-based brain morphometry.
Results A linear regression model revealed a significant interaction between age and depression score, indicating that depression-related cognitive dysfunction is more severe in older adults. A comparison of different cognitive domains showed that this effect was consistent across all tested domains but significantly more prominent for fluency. A complementary voxel-based morphometry analysis, based on similar regression models, revealed age by depression interactions in several brain regions, demonstrating preferential age-related reduction in grey matter volume in the left and right hippocampi in older adults. The reciprocal contrast revealed preferential reduction in grey matter in the left superior frontal gyrus, left middle frontal gyrus, and left superior parietal lobule in younger adults.
Conclusions These findings indicate that the associations of depression with cognitive performance and brain structure are age-dependent, suggesting that the neuropathological mechanisms underlying depression may differ between young and older adults. Recognizing these differences will support the development of better diagnostic tools and therapeutic interventions for depression across the lifespan.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Cam-CAN research was supported by the Biotechnology and Biological Sciences Research Council (BB/H008217/1). NW was supported by an Israel Science Foundation Personal Research Grant (1603/22).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research Ethics Committee of Cambridgeshire 2 gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request at Cam-CAN (Cambridge Centre for Ageing Neuroscience) dataset inventory.
